The challenge in systematic toxicological analysis using gas chromatography and/or liquid chromatography coupled to mass spectrometry is to identify compounds of interest from background noise. The large amount of spectral information collected in one full-scan MS run demands the use of automated evaluation of recorded data files. We evaluated the applicability of the freeware deconvolution software AMDIS (Automated Mass Spectral Deconvolution and Identification System) for GC-MS-based systematic toxicological analysis in urine for increasing the speed of evaluation and automating the daily routine workload.
BACKGROUND:
The challenge in systematic toxicological analysis using gas chromatography and/or liquid chromatography coupled to mass spectrometry is to identify compounds of interest from background noise. The large amount of spectral information collected in one full-scan MS run demands the use of automated evaluation of recorded data files. We evaluated the applicability of the freeware deconvolution software AMDIS (Automated Mass Spectral Deconvolution and Identification System) for GC-MS-based systematic toxicological analysis in urine for increasing the speed of evaluation and automating the daily routine workload.
METHODS:
We prepared a set of 111 urine samples for GC-MS analysis by acidic hydrolysis, liquid-liquid extraction, and acetylation. After analysis, the resulting data files were evaluated manually by an experienced toxicologist and automatically using AMDIS with deconvolution and identification settings previously optimized for this type of analysis. The results by manual and AMDIS evaluation were then compared.
RESULTS:
The deconvolution settings for the AMDIS evaluation were successfully optimized to obtain the highest possible number of components. Identification settings were evaluated and chosen for a compromise between most identified targets and general number of hits. With the use of these optimized settings, AMDISbased data analysis was comparable or even superior to manual evaluation and reduced by half the overall analysis time.
CONCLUSIONS: AMDIS proved to be a reliable and powerful tool for daily routine and emergency toxicology. Nevertheless, AMDIS can identify only targets present in the user-defined target library and may therefore not indicate unknown compounds that might be relevant in clinical and forensic toxicology. Systematic toxicological analysis (STA) 3 of drugs in biological specimens is important in clinical and forensic toxicology, workplace drug testing, and doping control (1) (2) (3) (4) (5) . Urine is the most widely used matrix for STA because comparatively large volumes can easily be collected noninvasively and because drugs and metabolites are concentrated in urine (1, 6 ) .
Analytical methods for STA should ideally cover hundreds of relevant drugs, poisons, and metabolites (1, 2, 7, 8 ) . This broad coverage can be achieved by use of GC-MS, HPLC with ultraviolet or diode-array detection, or HPLC coupled with single-stage LC-MS or LC-tandem MS (1, 3, 5, 9 -14 ) . Although LC-tandem MS has become increasingly important in recent years (9, 10 ) , in many laboratories routine STA is still performed by use of HPLC with ultraviolet or diode-array detection and GC-MS. GC-MS is still the gold standard for STA in urine samples (1, (15) (16) (17) , combining the separation power of GC with the high selectivity of electron ionization MS.
A disadvantage of GC-MS-based STA is that the evaluation of full-scan GC-MS data requires a high level of expertise and experience. A major challenge is the detection of analyte peaks in the total ion chromatograms (TIC), where they are often overlapped by more or less intense matrix peaks. One solution is the use of user-defined macros (2 ), which extract characteristic fragment ions from the total ion current, thus indicating the possible presence of the respective drugs and/or their metabolites. However, macro-based data evaluation is rather time-consuming and analytes not covered by the extracted ions may be overlooked.
Another option is the use of so-called deconvolution algorithms that extract pure compound peaks more or less free of overlapping signals from complex TICs. One of the software solutions based on this principle is the freeware program called AMDIS (Automated Mass Spectral Deconvolution and Identification System; http://chemdata.nist.gov/mass-spc/amdis/). AMDIS first deconvolutes pure component spectra and related information such as peak shape and retention time from complex chromatograms and subsequently matches the obtained spectra with those of a reference library, the so-called target library. AMDIS was originally developed in 1996 for the automated identification of chemical weapons and related compounds, but should be applicable to any method requiring extraction of mass spectra from noisy TIC and the identification of target compounds by fullspectrum matching (18 ) . So far, AMDIS has mainly been used in environmental chemistry (19 -24 ) . Only 2 reports have described AMDIS use in the context of clinical or forensic toxicology (25, 26 ) . The methods described in these reports are limited to blood analysis and are focused on a small number of analytes used with small in-house libraries.
Our aim in this study was to evaluate the applicability of AMDIS for automated evaluation data files from routine GC-MS-based STA in urine by using a modified target library version of the Maurer/Pfleger/ Weber MPW_2007 (27 ) . The workup used was found to be the method of choice for STA in clinical toxicology owing to its wide analyte spectrum and short workup time (28 ) . The study included optimization of the settings for deconvolution and library search and a systematic comparison of the AMDIS search results with results obtained by an experienced toxicologist using manual macro-assisted data evaluation.
Materials and Methods

CHEMICALS AND REAGENTS
Acetic anhydride, ammonium sulfate, pyridine, and disodium hydrogen phosphate (Na 2 HPO 4 | ⅐ |2 H 2 O) were obtained from Fluka. Sodium hydroxide pellets were obtained from Riedel-de Haen. All other chemicals were obtained from Merck. All chemicals were of analytical grade.
URINE SAMPLES
The studied urine samples were submitted to the authors' laboratory for STA. They were collected from a total number of 111 consecutive patients presenting with suspected intoxication/poisoning at the emergency department of the University of Mainz over a 1-year period (29 ) . Any required institutional review board demands for use of the submitted samples were fulfilled.
SAMPLE PREPARATION FOR SYSTEMATIC TOXICOLOGICAL
ANALYSIS
Urine samples were prepared as described previously (29, 30 ) . Briefly, the samples (5 mL) were divided into 2 aliquots (2.5 mL each), one of which was subjected to acid hydrolysis. Thereafter, the sample was adjusted to pH 8 -9 with 2 mL of 10 mol/L aqueous sodium hydroxide and the other aliquot of untreated urine was added. This mixture was extracted with 5 mL dichloromethane-isopropanol-ethyl acetate (1:1:3 vol/ vol/vol), and the organic layer was evaporated to dryness. The residue was acetylated with 100 L of an acetic anhydride-pyridine mixture (3:2 vol/vol) under microwave irradiation. After evaporation of the derivatization mixture, the residue was dissolved in 100 L of methanol and 2 L was injected into the GC-MS system.
GC-MS APPARATUS
The GC-MS settings for the STA analyses were used as described by Maurer et al. (30 ) . We used a Hewlett Packard (HP; Agilent) 5890 series II gas chromatograph combined with an HP 5972A MSD mass spectrometer. An HP MS ChemStation (DOS series) was used with HP G1034C software version C03.00. The GC conditions were as follows: splitless injection mode; column, HP-1 capillary (12 m ϫ 0.2 mm i.d.); cross-linked methyl silicone, film thickness 330 nm; injection port temperature 280°C; helium carrier gas flow-rate 1 mL/min; column temperature programmed from 100 -310°C at 30°/min, initial time 3 min, final time 8 min. The MS conditions were as follows: electron ionization mode, ionization energy 70 eV, ion source temperature 220°C, capillary direct interface 280°C; full-scan mode m/z 50 -550, 1 scan/s.
DATA ANALYSIS
Manual evaluation. The full-scan data files acquired by the GC-MS system were screened for the presence of peaks and mass spectra of (derivatized) drugs, metabolites, and artifacts by use of the Standalone Data Analysis feature of the HP Chem Station software. A first manual screen of the TIC by an experienced toxicologist was followed by screening for specific drug classes employing previously described user-defined macros (1, 2, 30 ) for the following drug classes: psychotropics, barbiturates, benzodiazepines, stimulants/hallucinogens, opioids, analgesics, anticonvulsants, antidepressants, butyrophenone neuroleptics, cardiovascular drugs, sedative hypnotics, and phenothiazine neuroleptics (1, 2, 30 ) . Identification was achieved by computer-assisted comparison of the peak underlying mass spectra with those of the Maurer/Pfleger/Weber MPW_2007 mass spectral library (27 ) .
AMDIS evaluation. The full-scan data files acquired by the GC-MS system were analyzed by AMDIS (http:// chemdata.nist.gov/mass-spc/amdis/) in simple mode. Library matches were visually inspected and verified by an experienced toxicologist before the respective compounds were reported. The final decision concerning the declaration of a library match to be a "true hit" was always done by a toxicologist on the basis of m/z correlations and their respective abundance. We generated an AMDIS-readable library using the Lib2NIST converter software version 1.0.0.13 included in the NIST MS-Search software version 2.0a. This converter can generate AMDIS-readable libraries (*.MSP file format, renamed to *.MSL) from the following database formats: HP (*.L), plain text (*.SDF), NIST, and JCAMP-DX (*.JDX; *.DX; *.HPJ; *.JX; *.JC; *.JCM). The used target library was a modified version of the Maurer/Pfleger/Weber MPW_2007 library (27 ) , from which all mass spectra of silylated and perfluoroacylated compounds had been eliminated by use of the "build one library" option contained in the AMDIS main program. The final settings of the deconvolution and search parameters were derived from the results of a series of optimization experiments. In the first experiment, we investigated the influence of the deconvolution settings on the number of targets proposed by the software. All 111 MS data files were deconvoluted under variation of single parameters while all others were held constant. The parameter settings used were as follows: width, 4, 8, 12, 16, 20, 24, 28, 32 ; adjacent peak subtraction, 0, 1, 2; resolution, low, medium, high; sensitivity, very low, low, medium, high, very high; and shape requirements, low, medium, high. Settings leading to a maximum number of targets proposed by the software were considered optimal.
In the second experiment, we performed deconvolution with the optimized settings derived from the first experiment, and varied the minimum match factor (MMF) (40, 50, 60, or 70) to find an optimal setting, avoiding false-negative findings, i.e., targets present in urine but not detected by AMDIS, while limiting the number of false-positive hits, i.e., targets proposed by the software but not present in the respective samples.
In the third experiment, we used the analysis type "Use Internal Standard for RI" with various internal standards. The 70 urine samples for which sufficient volumes were left after the first analysis were spiked with 100 L of a mixture of the internal standard: nomifensine (0.5 g/L), p-tolylpiperazine (0.1 g/L), and cyproheptadiene (0.1 g/L) and extracted again as described above. The following compounds were also used as an internal standard for AMDIS analysis if present in the samples: caffeine, nicotine, and diisooctylphthalate. The setting for retention index (RI)-aided analysis was as follows: RI window 100 ϩ 0, level infinite, and maximum penalty 30.
We performed all statistical evaluations using Graphpad Prism 3.02 software.
AMDIS VS MANUAL EVALUATION
Results obtained by AMDIS with the optimized deconvolution and search settings were compared to the results achieved after manual evaluation. Both data evaluation methods were performed independently of each other. Again, the final decision concerning the declaration of a library match to be a "true hit" was always made by a toxicologist on the basis of m/z correlation and respective abundance.
Results
The influence of the deconvolution parameters resolution and sensitivity on the number of targets proposed by the software is shown in Fig. 1 . The optimized deconvolution and identification parameters were as follows: width, 32; adjacent peak subtraction, 2; sensitivity, very high; resolution, high; shape requirement, low. These parameters were used in all further experiments.
With respect to the MMF, a setting of 50 was found to be the best compromise between true hits (targets proposed by the software present in urine) and false hits (targets proposed by the software not present in urine). Moreover, at this setting only one false-negative finding was observed. A lower MMF considerably increased the number of false hits, whereas at higher MMF the number of false-negative findings increased. When a higher MMF was used some compounds remained undetected. This can be seen in Table 1 , which lists the results obtained with MMF 50 and MMF 60 for the 24 samples in which fewer true hits were detected at MMF 60. Only the names of the parent drugs are listed, although in several cases their metabolites and/or artifacts have been detected. This can be verified via the given entry number in the used MPW_2007 library (27 ) .
The software allowed us to reduce the hits by 16 -96 (depending on the amount of identified compounds in the respective sample) with the so-called "Use internal standard for RI" mode. This mode applies penalties on the match factor for potential hits with an RI considerably different from the RI of the respective reference compound. With this procedure, however, overall 36 true hits were also eliminated from the 70 samples from the target list.
Comparison of the results obtained with the optimized AMDIS settings to those obtained by manual macroassisted data evaluation by an experienced toxicologist generally showed good agreement between both evaluation procedures. In only 1 sample was a true hit, namely phenobarbital, detected by manual evaluation that was not detected by AMDIS. In 15 samples, additional true targets were identified by AMDIS that had not been detected by manual data evaluation. These findings are listed in Table 2 . Most of these results were related to minor (metabolite) peaks, and none of these findings was relevant from an emergency toxicology perspective. Such findings could be relevant in forensic cases, however. The time required for AMDIS-based data evaluation was approximately 5-8 min, less than half the time required for manual macroassisted data evaluation (15-20 min).
Discussion
Our aim was to evaluate the applicability of AMDIS for automated evaluation data files from routine GC-MSbased STA in urine using a modified target library version of the MPW_2007 library (27 ) and, if applicable, to establish AMDIS in routine data evaluation (29 ) . In this library version, silylated and perfluoroacylated compounds were eliminated because they are not expected in acetylated urine extracts, and a smaller number of reference spectra increases the speed of deconvolution/matching while reducing the number of proposed hits.
On the basis of a scan rate of 1 scan per second, compound peaks were formed by 4 to 100 scans depending on the peak form (e.g., very small and sharp peaks for haloperidol or very broad for acetaminophen).
In a first step, the deconvolution settings were optimized. The settings leading to a maximum of number of detected components were considered optimum, because detection of a compound in the deconvolution step is a prerequisite for matching the mass spectrum of the respective component with those of the target library. In other words, this strategy was chosen to avoid false-negative findings. The strongest influence on the number of detected compounds, and therefore on the number of identified targets, is attributable to the parameters sensitivity and shape, whereas the influence of resolution and width is of minor relevance (see Fig. 1 ). The adjacent peak subtraction has no influence on the number of identified components in the MS data file, because this parameter is responsible only for the purity of the achieved spectrum.
With the above-mentioned optimized deconvolution settings, only a single small peak of phenobarbital found manually by an experienced toxicologist was not detected by AMDIS. This finding demonstrates that the probability of overlooking relevant peaks with these settings is very low. However, a disadvantage of optimizing deconvolution settings for detection of a maximum number of components is that even small matrix peaks are also detected, increasing the number of proposed target hits.
It is therefore essential to choose an appropriate MMF so that false-positive hits, caused by the more or less extensive similarity of their respective mass spectra with a target compound spectrum, are eliminated while none of the true positives are missed because of a too-high MMF. In the present study, an MMF of 50 was found to be the best compromise for limiting the number of proposed target compounds without overlooking true positives.
Lowering the MMF to 40 mainly increased the number of false-positive hits. Experience during routine analysis, however, has shown that evaluation (or reevaluation) of the entire TIC or parts of with a lower MMF can be reasonable if identification of even small peaks is important, e.g., in drug-facilitated crime cases or abstinence control. Using an MMF of 60 or higher was associated with a considerable risk of overlooking relevant analytes in the sample (Table 1) , unless the analytes were present in fairly high concentrations as, for example, in poisoning cases. Including the RI of the detected components in the search algorithm decreased the overall number of proposed hits, but was associated with a considerable risk of eliminating true-positive hits. This finding might be attributable to variations of the used RIs of the compounds contained in the AMDIS target library (31 ) and by the poor peak shape in some poisoning cases. Because the calculated RI does not depend on the internal standard used but instead the number of internal standards used to calculate the relative retention time, the choice of internal standard does not seem to be critical. In the authors' opinion, the reduction of proposed targets does not justify the risk of overlooking relevant analytes, as observed in the present study.
After we established the final AMDIS settings, we compared the results obtained with these settings to those obtained by manual macro-assisted data evaluation by an experienced toxicologist. The discrepancies are most likely attributable to the fact that the respective peaks had a very low abundance and that only a 1-sided background subtract was possible with the ChemStation software used for manual data evaluation. Hence, it was very difficult to obtain a clean mass spectrum, that is, one not overlaid by matrix spectra. The deconvolution algorithm of AMDIS allows a 2-sided background subtraction, resulting in much cleaner mass spectra that in turn lead to better highermatch factors. In summary, AMDIS proved to be a reliable and powerful tool for daily routine and emergency toxicology. The major advantages of using AMDIS are the better identification of even low-abundant peaks in the TIC and the reduction of the evaluation time by half. The decreased evaluation time is of particular relevance in clinical emergency toxicology where the speed of analysis is important. Results obtained by AMDISbased data evaluation are comparable or superior to results obtained by manual data evaluation. Nevertheless, it must be stated that AMDIS can identify only targets present in the user-defined target library and may therefore not indicate unknown compounds that 
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